These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4426059)

  • 21. Pharmacological analysis of chronotropic responses of the S-A node to caffeine.
    Chiba S; Hashimoto K; Hashimoto K
    Eur J Pharmacol; 1972 Apr; 18(1):116-20. PubMed ID: 5031269
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of (plus or minus)-propranolol, (plus or minus)-,(plus)-, and (minus)-alprenolol on unanaesthetized dogs with ventricular arrhythmias resulting from coronary artery ligation.
    Duce BR; Garberg L; Smith ER
    Br J Pharmacol; 1970 Aug; 39(4):809-16. PubMed ID: 4394971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central hypotensive activity of dl- and d-propranolol.
    Kelliher GJ; Buckley JP
    J Pharm Sci; 1970 Sep; 59(9):1276-80. PubMed ID: 5469791
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
    Trcka V; Vanĕcek M; Helfert I; Mácová S
    Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of adrenergic beta receptor blockaders on the circulation in cats].
    Greeff K; Köhler E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(1):79-86. PubMed ID: 4397216
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.
    Ablad B; Borg KO; Johnsson G; Regårdh CG; Sölvell L
    Life Sci; 1974 Feb; 14(4):693-704. PubMed ID: 4823626
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of prostaglandin E1 on blood pressure and heart rate in the dog. Prostaglandin and related factors 48.
    Carlson LA; Orö L
    Acta Physiol Scand; 1966 May; 67(1):89-99. PubMed ID: 4381452
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure.
    Tackett RL; Webb JG; Privitera PJ
    Science; 1981 Aug; 213(4510):911-3. PubMed ID: 7256285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible mechanism (s) of alprenolol (beta adrenergic receptor blocking agent) prolongation of pentobarbital hypnosis in mice.
    Peters MA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):417-24. PubMed ID: 4402372
    [No Abstract]   [Full Text] [Related]  

  • 31. A new procedure for studying central acting cardiovascular drugs: the permeabilization of the blood-brain barrier.
    Feldman J; Bousquet P
    Arch Int Pharmacodyn Ther; 1988; 296():7-17. PubMed ID: 3240024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mode of action of intravenous nicotine in causing a fall of blood pressure in the cat.
    Armitage AK; Hall GH
    Eur J Pharmacol; 1969 Jul; 7(1):23-30. PubMed ID: 5258818
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of D- and L-alprenolol on the isolated rat heart.
    Brus R; Drzewiecki J
    Pol J Pharmacol Pharm; 1973; 25(5):429-34. PubMed ID: 4777346
    [No Abstract]   [Full Text] [Related]  

  • 34. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
    Kleinrok Z; Ksiazek A
    Pol J Pharmacol Pharm; 1975; 27(2):177-82. PubMed ID: 239397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: Comparison of some haemodynamic changes between central and intravenous administration of (plus or minus)-propranolol in anaesthetized dogs.
    Carter JK; Mitchell HW; Poyser RH
    Br J Pharmacol; 1974 May; 51(1):146P-147P. PubMed ID: 4441787
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypotensive action of beta-blocking drugs injected into the cerebral ventricle of the rat.
    Wepierre J; Lindenbaum A; Porquet D; Cohen Y
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):158-65. PubMed ID: 27151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of some derivatives of indole and benzofuran].
    Il'iuchenok TIu; Frigidiva LM; Maksimenko AA; Trofimov FA
    Farmakol Toksikol; 1970; 33(5):576-81. PubMed ID: 5493217
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central action of drugs affecting beta-adrenergic receptor. II. The central action of intraventricularly applicated propranolol in rats.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):297-304. PubMed ID: 4859243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.